139-91-3
139-91-3
Chemical Structure
Furaltadone
Synonym(s): Altafur
- CAS No.: 139-91-3
- Formula:C13H16N4O6
- Molecular Weight:324.29
IUPAC Name: (E)-5-(morpholinomethyl)-3-(((5-nitrofuran-2-yl)methylene)amino)oxazolidin-2-one
InChIKey: YVQVOQKFMFRVGR-VGOFMYFVSA-N
SMILES: O=C1OC(CN2CCOCC2)CN1/N=C/C3=CC=C([N+]([O-])=O)O3
Biological Activity: Furaltadone, a nitrofuran agent, has the potential for the study in infections of chickens with salmonella enteritidis. Furaltadone is inhibitory and bactericidal in vitro for staphylococci [1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Furaltadone | 98.44% | Furaltadone, a nitrofuran agent, has the potential for the study in infections of chickens with salmonella enteritidis. Furaltadone is inhibitory and bactericidal in vitro for staphylococci . | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Furaltadone (Standard) | ≥98% | Furaltadone (Standard) is the analytical standard of Furaltadone. This product is intended for research and analytical applications. Furaltadone, a nitrofuran agent, has the potential for the study in infections of chickens with salmonella enteritidis. Furaltadone is inhibitory and bactericidal in vitro for staphylococci . | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Furaltadone-d5 | Furaltadone-d5 is the deuterium labeled Furaltadone (HY-B1148A). Furaltadone, a nitrofuran agent, has the potential for the study in infections of chickens with salmonella enteritidis. Furaltadone is inhibitory and bactericidal in vitro for staphylococci . | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. A.Rampling(Dr.), et al. The effect of furaltadone, a nitrofuran drug, on experimental infections of chickens with salmonella enteritidis phage Type 4. Pathology Volume 25, Supplement 1, 1993, Page 22.
- [2]. William R. McCabe, et al. Furaltadone — A Critical Evaluation of Clinical and Laboratory Studies. N Engl J Med 1960; 263:927-934.
